Medfinder
Back to blog

Updated: January 23, 2026

Symbravo Side Effects: What to Expect and When to Call Your Doctor

Author

Peter Daggett

Peter Daggett

Medication bottle with warning checklist of Symbravo side effects

Learn about Symbravo side effects — from common issues like dizziness to serious warnings about cardiovascular and GI risks — so you know what to watch for.

Symbravo (meloxicam 20 mg and rizatriptan 10 mg) is an FDA-approved medication for acute migraine — but like all prescription drugs, it comes with a range of potential side effects, from mild and manageable to rare but serious. Understanding what to expect helps you use Symbravo safely and know when something requires a call to your doctor or a trip to the emergency room.

Symbravo's Boxed Warning: The Most Serious Risks

Symbravo carries a Boxed Warning — the FDA's strongest safety label — for two categories of serious risk, both related to the meloxicam (NSAID) component:

Serious cardiovascular thrombotic events: NSAIDs can increase the risk of heart attack and stroke. This risk may occur early in treatment and may increase with longer use. Symbravo is contraindicated in patients with coronary artery disease, significant cardiovascular disease, or immediately after bypass (CABG) surgery.

Serious gastrointestinal adverse events: NSAIDs can cause bleeding, ulceration, and perforation of the stomach or intestines — sometimes without warning symptoms. Risk is higher in elderly patients and those taking corticosteroids, anticoagulants, SSRIs, or aspirin.

Common Side Effects of Symbravo

In clinical trials (MOMENTUM, INTERCEPT, MOVEMENT), the most commonly reported side effects with Symbravo (occurring in ≥1% of patients and more often than with placebo) were:

Dizziness — The most frequently reported side effect. Usually mild and transient. Avoid driving or operating heavy machinery if you experience significant dizziness.

Somnolence (drowsiness) — Also common. May contribute to driving impairment. Rest after taking Symbravo during a migraine attack if possible.

Additional side effects seen in clinical studies that included both the NSAID and triptan components:

Nausea and vomiting (also common migraine symptoms themselves)

Fatigue

Muscle tightness or pain

Chest, throat, neck, or jaw sensations (pressure, tightness, pain) — common with triptans; usually benign but requires evaluation if severe or associated with other symptoms

Serious Side Effects: When to Call Your Doctor or Call 911

Stop taking Symbravo and seek immediate medical attention if you experience:

Signs of heart attack or stroke: Chest pain, sudden severe headache, slurred speech, weakness or numbness in face, arm, or leg, sudden vision changes, difficulty breathing

GI bleeding: Blood in stool, black tarry stools, vomiting blood, or severe stomach pain

Serious allergic reaction: Hives, swelling of face/lips/tongue/throat, severe rash, difficulty breathing — seek emergency care immediately

Serious skin reactions: Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis — blistering, peeling skin, flu-like symptoms before rash development

Serotonin syndrome: Agitation, hallucinations, rapid heart rate, high fever, twitching muscles, nausea/vomiting/diarrhea — risk increased if taking SSRIs, SNRIs, or other serotonergic drugs

Signs of arrhythmia: Irregular heartbeat, palpitations, fainting

Kidney problems: Decreased urination, swelling in legs/feet/ankles, unexplained weight gain (fluid retention)

Special Populations: Additional Risks to Know

Certain groups face elevated risk from specific Symbravo components:

Pregnancy: NSAIDs should be avoided after 20 weeks of pregnancy due to risk of fetal kidney problems (oligohydramnios). Avoid after 30 weeks entirely. Discuss with your OB before taking Symbravo.

Fertility: NSAIDs are associated with reversible impairment of female fertility. Consider stopping Symbravo in women having difficulty conceiving.

Aspirin-sensitive asthma: Contraindicated in patients with history of asthma attacks, urticaria, or other reactions to aspirin or NSAIDs.

Medication Overuse Headache: A Lesser-Known Risk

Like all acute migraine medications, Symbravo can cause medication overuse headache (MOH) if used too frequently. MOH occurs when patients take acute migraine treatments on 10 or more days per month, which can paradoxically worsen headache patterns over time. The Symbravo label includes a warning for MOH, and detoxification may be necessary if this develops. Monitor your usage and discuss with your doctor if you're using Symbravo more than twice a week.

Tips to Minimize Side Effects

Take with food if GI upset occurs (though a high-fat meal significantly delays absorption)

Avoid alcohol after taking Symbravo — it can worsen GI risk and increase dizziness

Do not take more than one tablet per day

Do not take other NSAIDs or aspirin alongside Symbravo without consulting your doctor first

For a full guide on Symbravo drug interactions, see Symbravo Drug Interactions: What to Avoid and What to Tell Your Doctor.

Frequently Asked Questions

The most commonly reported side effects of Symbravo in clinical trials are dizziness and somnolence (drowsiness). These occur in more than 1% of patients and more often than with placebo. Nausea, fatigue, and muscle tightness were also reported in trials. Most mild side effects resolve on their own after the medication wears off.

No. Symbravo is contraindicated in patients with ischemic coronary artery disease or significant underlying cardiovascular disease. The meloxicam (NSAID) component carries a Boxed Warning for increased risk of serious cardiovascular events including heart attack and stroke. Patients with CV risk factors should discuss safer alternatives (such as gepants) with their doctor.

Yes. The meloxicam (NSAID) component of Symbravo carries a Boxed Warning for serious GI adverse events including bleeding, ulceration, and perforation of the stomach or intestines. These events can occur without warning. Risk is higher in elderly patients and those also taking anticoagulants, corticosteroids, aspirin, or SSRIs. Seek immediate medical care if you notice blood in stool, black tarry stools, or vomit that looks like coffee grounds.

Use caution. Symbravo commonly causes dizziness and somnolence, which can impair driving ability. The decision to drive should take into account how Symbravo affects you individually, as well as the migraine itself, which also impairs cognition. It's generally recommended to rest after taking Symbravo during a migraine episode when possible.

Medication overuse headache (MOH) occurs when acute migraine medications are used too frequently — typically 10 or more treatment days per month — leading to a paradoxical increase in headache frequency. Symbravo's label includes a warning for MOH. If you find yourself needing Symbravo more than twice per week, discuss this with your doctor before it becomes a chronic pattern.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Symbravo also looked for:

30,682 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,682 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?